The Evaluation of Orphan Drugs by the German Joint Federal Committee —A n Eight-Year Review
Dtsch Arztebl Int 2020; 117: 868-9. DOI: 10.3238/arztebl.2020.0868
Figure
Table
All Powerpoint slides Powerpoint slide Print image Save image